Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naive chronic lymphocytic leukaemia: Elevate-TN 6-year follow-up

Category Primary study
Conference64th Annual Scientific Meeting of the British Society for Haematology
Year 2024
This article has no abstract
Epistemonikos ID: d2dd5518427e247068cc8f11abf98329a77dc696
First added on: Jan 07, 2026